AARD vs DG · $284.4M cap vs P/E 15, rev $22.08B
Aardvark Therapeutics, Inc. Common Stock (AARD) versus Dollar General Corporation (DG) — a side-by-side from cached financials, not a winner call.
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
Dollar General Corporation (DG) is a discount stores company listed on US.
Latest reported AARD revenue for 2025-12-31 was $0. Net income was -$57.6M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AARD currently screens at market cap $284.4M.
Latest reported DG revenue for 2026-07-31 was $22.08B. Net income was $994.4M. DG currently screens at market cap $22.87B and trailing P/E 14.7.
AARD currently screens at market cap $284.4M. DG currently screens at market cap $22.87B and trailing P/E 14.7.
Not investment advice. Open the AARD and DG stock pages for the full models.
Not investment advice.